Taiwan Orders GSK Antibiotic Removed From Market Pending Report
This article was originally published in PharmAsia News
Executive Summary
Taiwan authorities ordered GlaxoSmithKline's Augmentin (amoxicillin) antibiotic recalled until the U.K.-based firm can explain the presence of a plasticizer in the drug